Sentences with phrase «u.s. government approval»

On July 20, 2016, Moon Express became the first company to receive U.S. government approval to send a robotic spacecraft beyond traditional Earth orbit and to the Moon.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Musk, of SpaceX and Tesla (TSLA) fame, recently tweeted that he had received «verbal» approval from the U.S. government to build a «Hyperloop,» a train system that would enable travel between Washington, D.C. and New York in just 29 minutes, some time in the near future.

Does anyone think the current discussions on raising the U.S. government's debt ceiling will result in anything other than approval?

He will also become the government's point man on the tricky Keystone XL pipeline project, which is still awaiting approval in the U.S.

The two companies did not mention any possible termination fees related to failing to secure regulatory approval, which may be a heightened concern given recent U.S. government opposition to big deals like Comcast - Time Warner Cable, Staples - Office Depot and General Electric - Electrolux.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«We urge U.S. Attorney Preet Bharara to cast as wide a net as possible and scrutinize every approval issued and every decision maker involved at every layer of government.

His comments remain powerful today as a plan to restore healthy wetlands along the shores of Lake Ontario and the St. Lawrence River awaits the approval of the U.S. and Canadian governments.

The proposed clinical trial, in which researchers would use CRISPR to engineer immune cells to fight cancer, won approval from the Recombinant DNA Advisory Committee (RAC) at the U.S. National Institutes of Health, a panel that has traditionally vetted the safety and ethics of gene therapy trials funded by the U.S. government and others.

However, Stitt says, as long as the U.S. government continues to list 2,000 IU as the safe upper threshold for vitamin D, it's been hard to get approval for experiments with doses higher than that in the United States.

There are also applications for at least 20 other reactors under scrutiny at the U.S. Nuclear Regulatory Commission (NRC)-- the government agency charged with monitoring the nation's reactors — including final approval of the AP - 1000 design.

«Furthermore, the U.S. Department of Education has made changes to the Elementary and Secondary Education Act state test review and approval process that will coerce states to adopt the federal government's preferred tests or risk billions in federal funding,» his office added in a statement.

For RIM, the stamp of approval from the U.S. government represents a key victory for the BlackBerry maker and could pave the way for the PlayBook to become commonplace in the upper echelons of power in Washington, similar to how the Waterloo, Ont. - based company's BlackBerry smartphones became standard issue on Capitol Hill.

It looks like the recently announced HTC Merge has been given the U.S. government's stamp of approval.

If the investor is FannieMae / FredicMac (Affiliates of the U.S. Government) ONLY then does your short sale package gets submitted to the investor — FannieMae / FredicMac — for approval.

The carrier filed an application with the U.S. Department of Transportation, and is currently awaiting government approval.

Delta currently flies to Shanghai from Seattle, Detroit and Tokyo Narita, and if it wins government approval, will add Los Angeles - Shanghai service in July, giving it a total of 28 flights a week from the U.S..

In a decision that strikes a blow against the federal government's controversial practice of excluding industry from consent decrees with environmental citizen groups, a practice known as «sue - and - settle,» the U.S. Court of Appeals for the Ninth Circuit overturned the district court's approval of a consent decree between a coalition of environmental groups and several federal agencies in Conservation Northwest v. Sherman, No. 11 - 35729 (9th Cir.

At the U.S. Energy Information Administration's (EIA) annual conference this week, one discussion honed in on the challenges to infrastructure approval and construction — as well as government's best role in developing projects that are key to U.S. energy transport and overall energy security.

Environment Minister Peter Kent says oil sands opponents «treacherous» Reuters «The right - of - center Conservative government was taken aback last week when the U.S. administration delayed approval of TransCanada Corp's proposed Keystone XL pipeline... Much to Kent's anger, two members of Parliament from the opposition New Democrats went to Washington this week to argue the pipeline should not go ahead until Canada has come up with a better plan to combat climate change.»

Government has so intervened into charity, at least in the U.S., that, people need to seek approval from a tax agency in order to perform a public good.

He's hinted at cutting out U.S. government involvement entirely and privatizing the entire student loan industry, one area that already comes with fewer forgiveness options and a more strict, credit - driven approval process.

The transaction between the two companies just needs to be finalized, which includes regulatory approval from the U.S. government.

The U.S. has just opened the first - of - its - kind Bitcoin futures for trading — a financial derivative that won the government's regulatory approval.

To help these families get approval for home loans, the U.S. government offers loan guarantees to take the place of private mortgage insurance.